MXC.AX Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (2 Apr 2024 @ 01:10):

MGC Pharmaceuticals Limited, a bio-pharma company, develops and supplies phytomedicines in worldwide. The company produces and supplies medicinal cannabis products; and non-cannabis phytomedicines...

Stats
Today's Volume	47 232.00
Average Volume	23 177.00
Market Cap	18.42M
EPS	$0 ( 2024-02-25 )
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-0.130
ATR14	$0.00200 (0.51%)

MGC Pharmaceuticals Ltd Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

MGC Pharmaceuticals Ltd Financials

Annual	2023
Revenue:	$3.39M
Gross Profit:	$698 740 (20.63 %)
EPS:	$-7.07

Q2	2024
Revenue:	$599 534
Gross Profit:	$-582 422 (-97.15 %)
EPS:	$-0.310

Q4	2023
Revenue:	$724 923
Gross Profit:	$-161 663 (-22.30 %)
EPS:	$-3.27

Q3	2022
Revenue:	$362 462
Gross Profit:	$26 537.00 (7.32 %)
EPS:	$-0.00150

Financial Reports:

No articles found.

MGC Pharmaceuticals Ltd

MGC Pharmaceuticals Limited, a bio-pharma company, develops and supplies phytomedicines in worldwide. The company produces and supplies medicinal cannabis products; and non-cannabis phytomedicines. Its principal product candidates include CimetrA, which is in phase III clinical trial for the symptomatic treatment of early COVID-19; CannEpil, a phase IIb cannabis-based therapy for drug-resistant Epilepsy; and CogniCann that is in phase II clinical trial for the symptomatic relief of Dementia. The company also provides ArtemiC range of products and cannabinoid products, as well as non-pharma products. In addition, it offers consulting services, including clinical research services. The company was formerly known as Erin Resources Limited and changed its name to MGC Pharmaceuticals Limited in December 2015. MGC Pharmaceuticals Limited was founded in 2014 and is based in West Perth, Australia.